ARCELLX INC's ticker is and the CUSIP is 03940C100. A total of 75 filers reported holding ARCELLX INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,759,768 | +12.8% | 216,270 | -0.6% | 0.02% | -20.0% |
| Q2 2023 | $6,881,587 | +39.2% | 217,634 | +35.6% | 0.02% | -66.2% |
| Q1 2023 | $4,943,249 | +880.7% | 160,443 | +886.1% | 0.07% | +722.2% |
| Q4 2022 | $504,045 | -63.2% | 16,270 | -77.7% | 0.01% | -65.4% |
| Q3 2022 | $1,370,000 | +197.2% | 73,003 | +186.3% | 0.03% | +100.0% |
| Q2 2022 | $461,000 | -60.4% | 25,498 | -69.3% | 0.01% | -58.1% |
| Q1 2022 | $1,163,000 | – | 82,965 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SR ONE CAPITAL MANAGEMENT, LP | 5,500,007 | $170,390,217 | 62.20% |
| PATHWAY CAPITAL MANAGEMENT, LP | 189,120 | $5,858,938 | 10.46% |
| NEA Management Company, LLC | 4,745,262 | $147,008,217 | 8.26% |
| Samsara BioCapital, LLC | 957,451 | $29,661,832 | 6.38% |
| Soleus Capital Management, L.P. | 1,102,447 | $34,153,808 | 4.90% |
| Cormorant Asset Management, LP | 2,075,000 | $64,284 | 4.30% |
| Paradigm Biocapital Advisors LP | 882,101 | $27,327,489 | 3.21% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,350,333 | $72,813,316 | 3.06% |
| Affinity Asset Advisors, LLC | 240,143 | $7,439,630 | 2.92% |
| CAXTON CORP | 36,302 | $1,124,640 | 2.87% |